Literature DB >> 33148096

Assessment of Pediatric Pseudotumor Cerebri Clinical Characteristics and Outcomes.

Erin Yamamoto1, Darren Farber2, David Rothner3, Manikum Moodley3.   

Abstract

Pseudotumor cerebri also known as idiopathic intracranial hypertension is a relatively uncommon disorder of unknown pathophysiology. Although pseudotumor cerebri occurs in both children and adults, the pseudotumor cerebri literature is heavily dominated by adult studies. The aim of this study is to retrospectively describe the clinical presentation, imaging, treatment, and outcomes of a large pediatric pseudotumor cerebri population over a 23-year period. We also discuss secondary pseudotumor cerebri (44%) as well as the increasingly recognized patient subgroups without headache (13.3%) and without papilledema (7.3%). Female sex, obesity, and initial symptoms were consistent with the literature; however radiographic findings were surprisingly low in this cohort. Headache outcomes at 1 week, 1 month, and 3 months following initial lumbar puncture/treatment and visual function outcomes are reported.

Entities:  

Keywords:  headache; idiopathic intracranial hypertension; outcome; papilledema; pseudotumor cerebri

Mesh:

Year:  2020        PMID: 33148096     DOI: 10.1177/0883073820972231

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

1.  Trends and Clinical Characteristics of Pediatric Patients Presenting to an Ophthalmology Emergency Department with an Initial Diagnosis of Optic Nerve Head Elevation.

Authors:  Kara M Cavuoto; Zahra Markatia; Annika Patel; Carla J Osigian
Journal:  Clin Ophthalmol       Date:  2022-05-18

Review 2.  Infantile idiopathic intracranial hypertension: case report and review of the literature.

Authors:  Francesco Del Monte; Laura Bucchino; Antonia Versace; Irene Tardivo; Emanuele Castagno; Giovanni Pieri; Giulia Pilloni; Enrico Felici; Antonio Francesco Urbino
Journal:  Ital J Pediatr       Date:  2022-01-10       Impact factor: 2.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.